Technology
Hyaluronic Acid Conjugation
Focusing on high-efficiency HA grafting and dissolvable microneedle technology, we create an innovative carrier platform with excellent skin compatibility and drug-loading capacity.
Hyaluronic Acid Carrier
Hydrophobic drug grafting breakthrough
The HA grafting efficiency to hydrophobic molecules increases from traditionally 30% to stably 90%!
Engineered carrier
Nanosized carrier enables body to absorb biomolecules more easily.
Innovative applications
Dissolving Transdermal Microneedle Patch
Vaccine Adjuvant Development
Drug Loaded in the Microneedle
Our gentle technique ensures the stability of biomolecules during originally harmful processing
Fast and Deep Permeation
See microneedle patch products >>
Dissolving Hyaluronic Acid Microneedle
Highly biocompatible material that triggers less inflammatory reaction at the applied area
Adjustable Delivery Depth Enabling Effective Drug Release
Advantages of HyoCrystal® microneedling:
Less Painful
More Bioavailable
Less Drug Waste
HA Vaccine Adjuvants
Developing a hyaluronic acid–grafted adjuvant with dual immune activation, capable of simultaneously inducing both Th1 and Th2 pathways to enhance vaccine protection and durability, supporting advanced vaccine development for cancer and infectious diseases.
AI-powered Immune Analysis
Integrating AI-assisted immune data analysis to combine test results with immune response patterns, enabling precise interpretation of vaccine or therapeutic outcomes. This enhances advances the development of personalized and precision medicine.
See ExoHybrid® product >>
Cellular biopharmaceuticals
EXOHYBRID® EXOSOMES PLUS
With a reinforced exosome carrier technology at its core, we have successfully developed a next-generation platform featuring high stability and high delivery efficiency.
By integrating blood-derived active molecules with functional exosomes, we provide innovative solutions that span regenerative medicine, aesthetics, and precision therapy.
Trademarks:
ExoHybrid® ExoFixture® 植泌素® 植密素®